Literature DB >> 21148558

Transport via the transcytotic pathway makes prostasin available as a substrate for matriptase.

Stine Friis1, Sine Godiksen, Jette Bornholdt, Joanna Selzer-Plon, Hanne Borger Rasmussen, Thomas H Bugge, Chen-Yong Lin, Lotte K Vogel.   

Abstract

The matriptase-prostasin proteolytic cascade is essential for epidermal tight junction formation and terminal epidermal differentiation. This proteolytic pathway may also be operative in a variety of other epithelia, as both matriptase and prostasin are involved in tight junction formation in epithelial monolayers. However, in polarized epithelial cells matriptase is mainly located on the basolateral plasma membrane whereas prostasin is mainly located on the apical plasma membrane. To determine how matriptase and prostasin interact, we mapped the subcellular itinerary of matriptase and prostasin in polarized colonic epithelial cells. We show that zymogen matriptase is activated on the basolateral plasma membrane where it is able to cleave relevant substrates. After activation, matriptase forms a complex with the cognate matriptase inhibitor, hepatocyte growth factor activator inhibitor (HAI)-1 and is efficiently endocytosed. The majority of prostasin is located on the apical plasma membrane albeit a minor fraction of prostasin is present on the basolateral plasma membrane. Basolateral prostasin is endocytosed and transcytosed to the apical plasma membrane where a long retention time causes an accumulation of prostasin. Furthermore, we show that prostasin on the basolateral membrane is activated before it is transcytosed. This study shows that matriptase and prostasin co-localize for a brief period of time at the basolateral plasma membrane after which prostasin is transported to the apical membrane as an active protease. This study suggests a possible explanation for how matriptase or other basolateral serine proteases activate prostasin on its way to its apical destination.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21148558      PMCID: PMC3037692          DOI: 10.1074/jbc.M110.186874

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Acute regulation of the epithelial sodium channel in airway epithelia by proteases and trafficking.

Authors:  Michael M Myerburg; Peter R Harvey; Elisa M Heidrich; Joseph M Pilewski; Michael B Butterworth
Journal:  Am J Respir Cell Mol Biol       Date:  2010-01-22       Impact factor: 6.914

2.  Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis.

Authors:  Karin List; Christian C Haudenschild; Roman Szabo; WanJun Chen; Sharon M Wahl; William Swaim; Lars H Engelholm; Niels Behrendt; Thomas H Bugge
Journal:  Oncogene       Date:  2002-05-23       Impact factor: 9.867

3.  Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine.

Authors:  Marguerite S Buzza; Sarah Netzel-Arnett; Terez Shea-Donohue; Aiping Zhao; Chen-Yong Lin; Karin List; Roman Szabo; Alessio Fasano; Thomas H Bugge; Toni M Antalis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-08       Impact factor: 11.205

4.  Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation.

Authors:  Sarah Netzel-Arnett; Brooke M Currie; Roman Szabo; Chen-Yong Lin; Li-Mei Chen; Karl X Chai; Toni M Antalis; Thomas H Bugge; Karin List
Journal:  J Biol Chem       Date:  2006-09-15       Impact factor: 5.157

Review 5.  Zymogen activation, inhibition, and ectodomain shedding of matriptase.

Authors:  Chen-Yong Lin; I-Chu Tseng; Feng-Pai Chou; Sheng-Fang Su; Ya-Wen Chen; Michael D Johnson; Robert B Dickson
Journal:  Front Biosci       Date:  2008-01-01

6.  Loss of matriptase suppression underlies spint1 mutation-associated ichthyosis and postnatal lethality.

Authors:  Roman Szabo; Peter Kosa; Karin List; Thomas H Bugge
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

7.  Ichthyosis, follicular atrophoderma, and hypotrichosis caused by mutations in ST14 is associated with impaired profilaggrin processing.

Authors:  Thomas Alef; Serena Torres; Ingrid Hausser; Dieter Metze; Umit Türsen; Gilles G Lestringant; Hans Christian Hennies
Journal:  J Invest Dermatol       Date:  2008-10-09       Impact factor: 8.551

8.  Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides.

Authors:  François Béliveau; Antoine Désilets; Richard Leduc
Journal:  FEBS J       Date:  2009-03-03       Impact factor: 5.542

9.  Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1.

Authors:  Karin List; Roman Szabo; Philip W Wertz; Julie Segre; Christian C Haudenschild; Soo-Youl Kim; Thomas H Bugge
Journal:  J Cell Biol       Date:  2003-11-24       Impact factor: 10.539

10.  The epidermal barrier function is dependent on the serine protease CAP1/Prss8.

Authors:  Céline Leyvraz; Roch-Philippe Charles; Isabelle Rubera; Marjorie Guitard; Samuel Rotman; Bernadette Breiden; Konrad Sandhoff; Edith Hummler
Journal:  J Cell Biol       Date:  2005-08-01       Impact factor: 10.539

View more
  24 in total

Review 1.  Membrane-anchored serine proteases in vertebrate cell and developmental biology.

Authors:  Roman Szabo; Thomas H Bugge
Journal:  Annu Rev Cell Dev Biol       Date:  2011-06-29       Impact factor: 13.827

2.  Essential role of endocytosis of the type II transmembrane serine protease TMPRSS6 in regulating its functionality.

Authors:  François Béliveau; Cédric Brulé; Antoine Désilets; Brandon Zimmerman; Stéphane A Laporte; Christine L Lavoie; Richard Leduc
Journal:  J Biol Chem       Date:  2011-07-01       Impact factor: 5.157

3.  The serine protease-mediated increase in intestinal epithelial barrier function is dependent on occludin and requires an intact tight junction.

Authors:  Natalie J Ronaghan; Judie Shang; Vadim Iablokov; Raza Zaheer; Pina Colarusso; Sébastien Dion; Antoine Désilets; Richard Leduc; Jerrold R Turner; Wallace K MacNaughton
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-04       Impact factor: 4.052

4.  Matriptase-mediated cleavage of EpCAM destabilizes claudins and dysregulates intestinal epithelial homeostasis.

Authors:  Chuan-Jin Wu; Xu Feng; Michael Lu; Sohshi Morimura; Mark C Udey
Journal:  J Clin Invest       Date:  2017-01-17       Impact factor: 14.808

5.  Alpha-1 Antitrypsin-Deficient Macrophages Have Increased Matriptase-Mediated Proteolytic Activity.

Authors:  Karina Krotova; George W Marek; Rejean L Wang; George Aslanidi; Brad E Hoffman; Nazli Khodayari; Farshid N Rouhani; Mark L Brantly
Journal:  Am J Respir Cell Mol Biol       Date:  2017-08       Impact factor: 6.914

6.  Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.

Authors:  Kazuyo Kohama; Makiko Kawaguchi; Tsuyoshi Fukushima; Chen-Yong Lin; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2012-12-18       Impact factor: 4.174

7.  Prostasin is required for matriptase activation in intestinal epithelial cells to regulate closure of the paracellular pathway.

Authors:  Marguerite S Buzza; Erik W Martin; Kathryn H Driesbaugh; Antoine Désilets; Richard Leduc; Toni M Antalis
Journal:  J Biol Chem       Date:  2013-02-26       Impact factor: 5.157

8.  The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.

Authors:  Stine Friis; Katiuchia Uzzun Sales; Jeffrey Martin Schafer; Lotte K Vogel; Hiroaki Kataoka; Thomas H Bugge
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

9.  A matriptase-prostasin reciprocal zymogen activation complex with unique features: prostasin as a non-enzymatic co-factor for matriptase activation.

Authors:  Stine Friis; Katiuchia Uzzun Sales; Sine Godiksen; Diane E Peters; Chen-Yong Lin; Lotte K Vogel; Thomas H Bugge
Journal:  J Biol Chem       Date:  2013-05-14       Impact factor: 5.157

10.  Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase.

Authors:  Brian R Larsen; Simon D R Steffensen; Nis V L Nielsen; Stine Friis; Sine Godiksen; Jette Bornholdt; Christoffer Soendergaard; Annika W Nonboe; Martin N Andersen; Steen S Poulsen; Roman Szabo; Thomas H Bugge; Chen-Yong Lin; Hanne Skovbjerg; Jan K Jensen; Lotte K Vogel
Journal:  Exp Cell Res       Date:  2013-01-16       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.